Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9731023
Somatostatin receptor-based cancer therapy
granted -
US 9732114
Compounds having anti-adhesive effects on cancer cells
granted -
US 9724344
Enhanced delivery of drug compositions to treat life threatening infections
granted -
US 9725520
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted -
US 9725460
Oridonin analogs, compositions, and methods related thereto
granted -
US 9719086
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 9719087
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 9719088
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 9701676
Pro-neurogenic compounds
granted -
US 9701758
Anti-CD19 scFv (FMC63) polypeptide
granted -
US 9695223
Engineered xylose transporters with reduced glucose inhibition
granted -
US 9695246
Anti-OX40 antibodies and methods of using the same
granted -
US 9687551
Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
granted -
US 9675544
Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
granted -
US 9675615
2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections
granted -
US 9675550
Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
granted -
US 9675663
TUSC2 therapies
granted -
US 9675633
miRNA for treating cancer and for use with adoptive immunotherapies
granted -
US 9669016
Antiparasitic effect of Bis[3,5-Bis(Benzylidene)-4-Oxo-1-Piperidinyl]amide Derivatives
granted -
US 9670254
VMP-like sequences of pathogenic Borrelia species and strains
granted -
US 9663504
Salts of heterocyclic modulators of HIF activity for treatment of disease
granted -
US 9662424
Hydrogel membrane for adhesion prevention
granted -
US 9656001
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 9655909
Personalized medicine for the prediction of therapy targeting the hedgehog pathway
granted